Valeant, meanwhile, announced a bid to buy Allergan Inc. (NYSE:AGN) for $45.7 billion, part of its announced strategy to join the ranks of the world’s five biggest drugmakers. Allergan, Inc. (NYSE:AGN) stock performance was 15.25% in last session and finished the day at $163.65. Traded volume was 32.43million shares in the last session and the…
Gilead Sciences, Inc. (NASDAQ:GILD) company on Mar. 28 announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for conversion on or after February 1, 2014 entirely in cash. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.92% in last session and finished…
Select Medical Holdings Corporation (NYSE:SEM), announced that the company has completed its private placement of $110.0 million in aggregate principal amount of its 6.375% senior notes due 2021 (the “Additional Notes”) as additional notes under the indenture pursuant to which it previously issued $600.0 million of 6.375% senior notes due 2021. Select intends to use…
